Report an error
Spotted something inaccurate in “GLP-1 Receptor Agonists Show Complex Risk-Benefit Profile for Eating Disorders”? Tell us what’s wrong and we’ll check it against the original source.
This form is for factual corrections. We read every report but cannot reply individually.